• Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Virtual - Americas - EST , United States

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS […]

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Virtual - Americas - EST , United States

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle applications you can’t achieve with the QIAGEN Ingenuity Pathway […]

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Virtual Global Event (Times shown in EST)

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few […]

  • Exploring pan-cancer immunomodulators for biomarker discovery and validation using TCGA and public single-cell data

    Virtual - Americas - EST , United States

    Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to: • View host immune response clusters across TCGA samples • Identify differentially expressed immunomodulators across sample groups […]

  • Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

    Virtual - EMEA - CET

    This webinar is for data scientists and bioinformaticians working in biopharma who need extensive high-quality omics data for target discovery efforts. Learn how to programmatically discover, retrieve, filter, aggregate, and analyze omics data from QIAGEN’s extensive repositories of deeply-curated multi-omics data. Attendees will learn how to leverage extensive metadata to find and combine datasets of […]

  • RNA-seq data analysis and interpretation using QIAGEN CLC and QIAGEN IPA

    Virtual - Americas - EST , United States

    This 120-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). For RNA-seq data, you will learn how to: • Import FASTQ files, cell matrix files and metadata and how to download references • Map reads to a reference genome […]

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    Virtual Global Event (Times shown in EST)

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled manually curated content and […]

  • Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome, proteome, and metabolome. Through a series of brief technical vignettes, it is demonstrated how to: · Generate associations among molecular signatures obtained via integrating multi-omics data · Extract mechanisms from […]

  • What's new in QIAGEN IPA Fall Release 2023?

    Virtual - EMEA - CET

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to […]

  • What's new in QIAGEN IPA Fall Release 2023?

    Virtual - Americas - EST , United States

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to […]

  • Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease Diagnostics

    Virtual - Americas - EST , United States

    Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host DNA and RNA in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing the diagnosis and treatment of diseases, with applications in a range of areas, including oncology, human host gene expression (transcriptomics), and antimicrobial infections […]

  • ASHG 2023

    Washington DC, United States

    This year at the American Society for Human Genetics (ASHG) 2023 Annual Meeting, QIAGEN will be showcasing our Sample to Insight solutions for human genetics at booth #902. Learn more about our products and solutions and receive complimentary demos of our bioinformatic software and databases. Our experts will be available to chat with you and […]